default author photo

Stefano Raniolo

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

28

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Pharmacological inhibition of CXCR4 increases the anti-tumor activity of conventional and targeted therapies in B-cell lymphoma models

Number of pages: 46 Posted: 10 Mar 2026
Laura Barnabei, Alberto J. Arribas, Luciano Cascione, Gabriela Forestieri, Eleonora Cannas, Francesca Guidetti, Filippo Spriano, Elisa Civanelli, Chiara Tarantelli, Samuele Di Cristofano, Stefano Raniolo, Andrea Rinaldi, Anastasios Stathis, Davide Rossi, Prof. Dr. Emanuele Zucca, Vittorio Limongelli, Johann Zimmermann and Francesco Bertoni
University of Turin, Department of Law, affiliation not provided to SSRN, Institute of Oncology Research (IOR), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Oncology Institute of Southern Switzerland, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 28 (1,399,036)

Abstract:

Loading...

CXCR4 inhibition, Drug resistance in B-cell lymphoma, BTK inhibitor synergy, NF-κB/AKT/MYC signaling pathways, Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)